メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Germline Pathogenic Variants in 7636 Japanese Patients with Prostate Cancer and 12 366 Controls

  • Yukihide Momozawa
  • , Yusuke Iwasaki
  • , Makoto Hirata
  • , Xiaoxi Liu
  • , Yoichiro Kamatani
  • , Atsushi Takahashi
  • , Kokichi Sugano
  • , Teruhiko Yoshida
  • , Yoshinori Murakami
  • , Koichi Matsuda
  • , Hidewaki Nakagawa
  • , Amanda B. Spurdle
  • , Michiaki Kubo

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

98   !!Link opens in a new tab 被引用数 (Scopus)

抄録

Background: Genetic testing has been conducted in patients with prostate cancer (PCa) using multigene panels, but no centralized guidelines for genetic testing exist. To overcome this limitation, we investigated the demographic and clinical characteristics of patients with pathogenic variants. Methods: We sequenced eight genes associated with hereditary PCa in 7636 unselected Japanese patients with PCa and 12 366 male, cancer-free control individuals. We assigned clinical significance for all 1456 variants using the American College of Medical Genetics and Genomics guidelines and ClinVar. We compared the frequency of carriers bearing pathogenic variants between cases and control participants with calculated PCa risk in each gene and documented the demographic and clinical characteristics of patients bearing pathogenic variants. All statistical tests were two-sided. Results: We identified 136 pathogenic variants, and 2.9% of patients and 0.8% of control individuals had a pathogenic variant. Association with PCa risk was statistically significant for variants in BRCA2 (P <. 001, odds ratio [OR] = 5.65, 95% confidence interval [CI] = 3.55 to 9.32), HOXB13 (P <. 001, OR = 4.73, 95% CI = 2.84 to 8.19), and ATM (P <. 001, OR = 2.86, 95% CI = 1.63 to 5.15). We detected recurrent new pathogenic variants such as p.Gly132Glu of HOXB13. Patients with pathogenic variants were 2.0 years younger at diagnosis and more often had smoking and alcohol drinking histories as well as family histories of breast, pancreatic, lung, and liver cancers. Conclusions: This largest sequencing study of PCa heredity provides additional evidence supporting the latest consensus among clinicians for developing genetic testing guidelines for PCa.

本文言語英語
論文番号djz124
ページ(範囲)369-376
ページ数8
ジャーナルJournal of the National Cancer Institute
巻112
号4
DOI
出版ステータス出版済み - 01-04-2020
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究

フィンガープリント

「Germline Pathogenic Variants in 7636 Japanese Patients with Prostate Cancer and 12 366 Controls」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル